Drug
Azd7442
Azd7442: highest development phase Phase 3, developed by AstraZeneca. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- AstraZeneca
Trials
| Drug | Phase | Indication |
|---|---|---|
| AZD7442 NCT04625725 | Phase 3 | COVID-19 |
| AZD7442 NCT04625972 | Phase 3 | COVID-19 |
Latest
No recent events.
Follow Azd7442 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.